ProQR (PRQR) - Company Short-Term Debt

ProQR Therapeutics NV - graphic logo of issuer PRQR

The price trend for ProQR Therapeutics N.V. (PRQR) allows for an assessment of its RNA-based drug development strategy. The current indicator stands at 0.01. The business relies on partnerships with industry behemoths, confirming confidence in the team's competencies. Meanwhile, a steady cash flow is absent, as the company allocates resources to research and does not yet have regular sales.

PRQR ProQR Therapeutics N.V. Short-Term Debt (07/04/2022 - 10/30/2026)

Analytical breakdowns for ProQR (PRQR)

- current quotes and average value forecast:
Price Chart ProQR Therapeutics NV|PRQR - Forecast Levels Chart
- market capitalization indicators:
Market Value ProQR Therapeutics|PRQR - Value Adjusted for Debt and Cash
- shareholders' equity book value data:
Net Assets per Single Share ProQR Therapeutics N.V.|PRQR - Total Stockholders' Equity|Market Value to Book Value Ratio proqr.com|PRQR - Company Balance Sheet Assets
- debt obligations and liquidity statistics:
Debt to Equity ProQR Therapeutics N.V.|PRQR - Long-Term Debt to Capital Coefficient|Short-Term Debt to Equity Ratio ProQR Therapeutics NV|PRQR - Aggregate Debt Obligations|Debt to Book Value ProQR Therapeutics|PRQR - Amount of Long-Term Liabilities|Company Short-Term Debts ProQR Therapeutics N.V.|Quick Ratio proqr.com
- earnings and multiples data:
PRQR - Company Net Income
General company analysis:proqr.com - PRQR
Mass-produced product of ProQR Therapeutics N.V.

Long-term investing requires strict liquidity control to minimize credit risks. The specificity of ProQR Therapeutics N.V. (PRQR) lies in the monetization of the Axiomer platform through strategic partnerships. This current liability metric accumulates all obligations with a maturity of up to one year, measuring the short-term financial burden. Stable advances from pharma behemoths allow the company to effectively service these loans. Such a capital structure guarantees high business resilience.

Who ProQR Therapeutics N.V. competes with

TEM - Company Short-Term Debt|Current Liabilities QGEN|Ionis Pharma (IONS) - Company Short-Term Debt|Repligen Inc. - Company Short-Term Loans and Borrowings|Company Short-Term Debt Avidity Biosciences|Short-Term Debt crisprtx.com CRSP|Company Short-Term Debt GeneDx (WGS)|Ultragenyx Pharmaceutical Inc. (RARE) - Short-Term Indebtedness|Company Short-Term Debt Beam Therapeutics Corp BEAM|Company Short-Term Loans and Borrowings SRPT|TWST: Company Current Liabilities|Company Short-Term Loans and Borrowings TXG (10xgenomics.com)|NTLA (Intellia Therapeutics, Inc.) - Company Current Liabilities|STOK: Amount of Current Liabilities|BLFS (BioLife Corp) - Company Short-Term Debts|WVE: Company Short-Term Loans and Borrowings|Company Short-Term Debts MAZE|SION - Short-Term Debt|Company Short-Term Debt Prime Medicine PRME|Company Short-Term Loans and Borrowings TSHA|uniQure Corp - Company Short-Term Debts|MGTX - Company Short-Term Debts|REGENXBIO Inc. (RGNX) - Company Short-Term Debt|Current Liabilities SLDB (solidbio.com)|OCGN (Ocugen) - Company Short-Term Debts|Short-Term Debt Pacific Biosciences of California, Inc. PACB|Company Current Liabilities BNTC (Benitec)|Company Short-Term Debts Design Corp (DSGN)|Rocket Pharmaceuticals - Company Current Liabilities|Amount of Current Liabilities FDMT (4dmoleculartherapeutics.com)|Lexeo - Company Short-Term Debts|Short-Term Debt Volume Korro Bio, Inc. KRRO|EDIT: Company Short-Term Debts|Company Current Liabilities Silence Therapeutics Corp|Company Short-Term Debt Codexis Inc|sangamo.com (SGMO) - Short-Term Debt Volume|Company Current Liabilities NAUT (Nautilus Biotechnology)|MGX (Metagenomi Inc.) - Company Short-Term Loans and Borrowings|Company Short-Term Debt Precision BioSciences DTIL|GBIO: Company Short-Term Indebtedness|BOLD: Company Current Liabilities|Short-Term Debt Volume Exicure, Inc. XCUR|IMNN (imunon.com) - Company Current Liabilities|PHIO (Phio Pharmaceuticals Corp.) - Company Short-Term Debt|Company Current Liabilities MBIO|TransCode (RNAZ) - Short-Term Debt Volume|Company Short-Term Debt Bionano Genomics, Inc. (BNGO)|APDN: Current Liabilities|Company Short-Term Debt bluebird bio BLUE|Company Short-Term Loans and Borrowings IPA|OMGA - Company Short-Term Debt|Short-Term Indebtedness Singular Genomics Corp (OMIC)|Regulus Therapeutics (RGLS) - Company Short-Term Debt|syros.com - Company Short-Term Loans and Borrowings|TBIO (Telesis Bio) - Company Short-Term Debts|Company Short-Term Indebtedness TCON (TRACON Pharmaceuticals Inc.)|Company Short-Term Debt Unity Bio (UBX)